Alzheimer's Disease Drugs and Diagnostics Market Report

China Alzheimer's Disease Drugs and Diagnostics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：206
  • REPORT CODE：GMM1787760
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Alzheimer's disease (AD) is a progressive degenerative neurological degenerative disease. Clinically, it is characterized by memory impairment, aphasia, misuse, loss of recognition, visual spatial impairment, executive dysfunction, and personality and behavioral changes such as personality dementia. The etiology has not been known so far.

    This report elaborates on the current development of the Alzheimer's Disease Drugs and Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GE Healthcare

    • Accera

    • Eisai Co Ltd

    • Treventis Corporation

    • Neuro-Bio Ltd

    • Johnson & Johnson

    • Roche Holding AG

    • Alector LLC

    • TauRx

    • Eli Lilly and Company

    • Biogen Inc

    By Type:

    • Drugs

    • Diagnostics

    By Application:

    • Clinics

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Alzheimer's Disease Drugs and Diagnostics Market Overview 2018-2029

    • 1.1 China Alzheimer's Disease Drugs and Diagnostics Industry Development Overview

    • 1.2 China Alzheimer's Disease Drugs and Diagnostics Industry Development History

    • 1.3 China Alzheimer's Disease Drugs and Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Alzheimer's Disease Drugs and Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Alzheimer's Disease Drugs and Diagnostics Production Volume, Production Value and Growth Rate of Drugs (2018-2029)

      • 1.4.2 China Alzheimer's Disease Drugs and Diagnostics Production Volume, Production Value and Growth Rate of Diagnostics (2018-2029)

    • 1.5 China Alzheimer's Disease Drugs and Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Alzheimer's Disease Drugs and Diagnostics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China Alzheimer's Disease Drugs and Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Alzheimer's Disease Drugs and Diagnostics Market Analysis by Region

      • 1.6.1 North China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Alzheimer's Disease Drugs and Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Alzheimer's Disease Drugs and Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Alzheimer's Disease Drugs and Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Alzheimer's Disease Drugs and Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Alzheimer's Disease Drugs and Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Alzheimer's Disease Drugs and Diagnostics Industry Development

    Chapter 3 Alzheimer's Disease Drugs and DiagnosticsIndustry Chain Analysis

    • 3.1 Alzheimer's Disease Drugs and Diagnostics Industry Chain

    • 3.2 Alzheimer's Disease Drugs and Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Alzheimer's Disease Drugs and Diagnostics Market

    • 3.3 Alzheimer's Disease Drugs and Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Alzheimer's Disease Drugs and Diagnostics Market

    Chapter 4 China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 4.1 China Alzheimer's Disease Drugs and Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Alzheimer's Disease Drugs and Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Alzheimer's Disease Drugs and Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Alzheimer's Disease Drugs and Diagnostics Production Volume and Growth Rate of Drugs

      • 4.5.2 China Alzheimer's Disease Drugs and Diagnostics Production Volume and Growth Rate of Diagnostics

    Chapter 5 China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Alzheimer's Disease Drugs and Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate of Clinics

      • 5.5.2 China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate of Hospital

    Chapter 6 China Alzheimer's Disease Drugs and Diagnostics Market, by Region

    • 6.1 China Alzheimer's Disease Drugs and Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Alzheimer's Disease Drugs and Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 7.1 North China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 7.2 North China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 8 Central China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 8.1 Central China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 8.2 Central China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 9 South China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 9.1 South China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 9.2 South China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 10 East China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 10.1 East China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 10.2 East China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 11 Northeast China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 11.1 Northeast China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 11.2 Northeast China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 12 Southwest China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 12.1 Southwest China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 12.2 Southwest China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 13 Northwest China Alzheimer's Disease Drugs and Diagnostics Market Analysis

    • 13.1 Northwest China Alzheimer's Disease Drugs and Diagnostics Market, by Type

    • 13.2 Northwest China Alzheimer's Disease Drugs and Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GE Healthcare

        • 14.1.1 GE Healthcare Company Profile

        • 14.1.2 GE Healthcare Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Accera

        • 14.2.1 Accera Company Profile

        • 14.2.2 Accera Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eisai Co Ltd

        • 14.3.1 Eisai Co Ltd Company Profile

        • 14.3.2 Eisai Co Ltd Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Treventis Corporation

        • 14.4.1 Treventis Corporation Company Profile

        • 14.4.2 Treventis Corporation Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Neuro-Bio Ltd

        • 14.5.1 Neuro-Bio Ltd Company Profile

        • 14.5.2 Neuro-Bio Ltd Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson

        • 14.6.1 Johnson & Johnson Company Profile

        • 14.6.2 Johnson & Johnson Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Roche Holding AG

        • 14.7.1 Roche Holding AG Company Profile

        • 14.7.2 Roche Holding AG Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Alector LLC

        • 14.8.1 Alector LLC Company Profile

        • 14.8.2 Alector LLC Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 TauRx

        • 14.9.1 TauRx Company Profile

        • 14.9.2 TauRx Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lilly and Company

        • 14.10.1 Eli Lilly and Company Company Profile

        • 14.10.2 Eli Lilly and Company Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Biogen Inc

        • 14.11.1 Biogen Inc Company Profile

        • 14.11.2 Biogen Inc Alzheimer's Disease Drugs and Diagnostics Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Alzheimer's Disease Drugs and Diagnostics Industry Research Conclusions

    • 15.2 Alzheimer's Disease Drugs and Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Alzheimer's Disease Drugs and Diagnostics Industry Market Size (2018-2029)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Volume, Production Value and Growth Rate of Drugs (2018-2029)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Volume, Production Value and Growth Rate of Diagnostics (2018-2029)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Alzheimer's Disease Drugs and Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Share by Type in 2018

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Share by Type in 2023

    • Figure China Alzheimer's Disease Drugs and Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Volume and Growth Rate of Drugs (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Volume and Growth Rate of Diagnostics (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Share by Application in 2018

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Share by Application in 2023

    • Figure China Alzheimer's Disease Drugs and Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Production Volume by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Production Value by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Production Value Share by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Sales Value by Region (2018-2023)

    • Table China Alzheimer's Disease Drugs and Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Alzheimer's Disease Drugs and Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table North China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table South China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table East China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Alzheimer's Disease Drugs and Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Alzheimer's Disease Drugs and Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Alzheimer's Disease Drugs and Diagnostics Sales Volume Share by Application (2018-2023)

    • Table GE Healthcare Company Profile

    • Table GE Healthcare Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Accera Company Profile

    • Table Accera Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Eisai Co Ltd Company Profile

    • Table Eisai Co Ltd Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Treventis Corporation Company Profile

    • Table Treventis Corporation Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Neuro-Bio Ltd Company Profile

    • Table Neuro-Bio Ltd Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Roche Holding AG Company Profile

    • Table Roche Holding AG Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Alector LLC Company Profile

    • Table Alector LLC Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table TauRx Company Profile

    • Table TauRx Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Biogen Inc Company Profile

    • Table Biogen Inc Alzheimer's Disease Drugs and Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US